<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01396889</url>
  </required_header>
  <id_info>
    <org_study_id>Echinacea in URIs</org_study_id>
    <nct_id>NCT01396889</nct_id>
  </id_info>
  <brief_title>Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years</brief_title>
  <official_title>Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years in Bandarabbas Children' Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hormozgan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hormozgan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute upper respiratory tract infections are the most commmon infections in children and are
      associated with complications such as acute otitis media, sinusitis and pneumonia. Echinacea
      is widely used for treatment of upper respiratoty tract infections. The aim of this study is
      to evaluate its efficacy as prophilaxis in children 1-5 years old.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence of upper respiratory tract infection diagnosed by physician according to history and physical examination and laboratory tests if was necessary</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Drug side effects</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Upper Respiratory Tract Infections</condition>
  <arm_group>
    <arm_group_label>Echinacea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5ml daily for children 1-2 years old and 2ml daily for children2-5 years old for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Echinacea</intervention_name>
    <description>0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old</description>
    <arm_group_label>Echinacea</arm_group_label>
    <other_name>American Cone Flower</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo (0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old) for 3 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Childrens 1-5 years old

        Exclusion Criteria:

          -  Wheezing in previous 3 months requiring bronchodilatator

          -  History of hyperactive reactive airway

          -  using steroid or Echinacea

          -  chronic pulmonary of cardiac disease

          -  Acute respiratory disease within one week before study

          -  Allergic rhinitis

          -  Allergy to Echinacea

          -  avoiding to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roya Firoozi, Resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hormozgan University of Medical Sciences (HUMS)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hormozgan University of Medical Sciences (HUMS)</name>
      <address>
        <city>Bandar Abbas</city>
        <state>Hormozgan</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2011</study_first_submitted>
  <study_first_submitted_qc>July 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2011</study_first_posted>
  <last_update_submitted>July 20, 2011</last_update_submitted>
  <last_update_submitted_qc>July 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Roya Firoozi</name_title>
    <organization>Hormozgan University of Medical Sciences (HUMS)</organization>
  </responsible_party>
  <keyword>Upper Respiratory Tract Infections</keyword>
  <keyword>Echinacea</keyword>
  <keyword>viral infections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

